Quick10K

⚲

Liberated Solutions

Filings

10-Q	2019-09-30	Filed 2019-11-07
10-Q	2019-06-30	Filed 2019-08-19
10-Q	2019-03-31	Filed 2019-05-13
10-Q	2018-12-31	Filed 2019-02-11
10-K	2018-09-30	Filed 2019-01-10
10-Q	2018-06-30	Filed 2018-08-20
10-Q	2018-03-31	Filed 2018-05-11
10-Q	2017-12-31	Filed 2018-02-12
10-K	2017-09-30	Filed 2018-01-12
10-Q	2017-06-30	Filed 2017-08-10
10-Q	2017-03-31	Filed 2017-05-15
10-Q	2016-12-31	Filed 2017-02-21
10-K	2016-09-30	Filed 2017-01-17
10-Q	2016-06-30	Filed 2016-08-22
10-Q	2016-03-31	Filed 2016-05-23
10-Q	2015-12-31	Filed 2016-02-22
10-K	2015-09-30	Filed 2016-01-13
10-Q	2015-06-30	Filed 2015-08-19
10-Q	2015-03-31	Filed 2015-05-20
10-Q	2014-12-31	Filed 2015-02-24
10-K	2014-09-30	Filed 2015-01-14
10-Q	2014-06-30	Filed 2014-08-21
10-Q	2014-03-31	Filed 2014-05-20
10-Q	2013-12-31	Filed 2014-02-14
10-K	2013-09-30	Filed 2014-01-13
10-Q	2013-06-30	Filed 2013-08-16
10-Q	2013-03-31	Filed 2013-05-20
10-Q	2012-12-31	Filed 2013-02-19
10-Q	2012-12-31	Filed 2013-02-20
10-K	2012-09-30	Filed 2012-12-10
10-Q	2012-06-30	Filed 2012-08-20
10-Q	2012-03-31	Filed 2012-05-21
10-Q	2011-12-31	Filed 2012-02-17
10-Q	2011-06-30	Filed 2011-08-15
10-Q	2011-03-31	Filed 2011-06-03

Reports

8-K	2020-07-24
8-K	2020-03-31
8-K	2020-03-17
8-K	2020-01-10
8-K	2019-12-30
8-K	2019-12-06
8-K	2019-10-28
8-K	2019-10-02
8-K	2019-09-27
8-K	2019-09-23
8-K	2019-09-16
8-K	2019-09-04
8-K	2019-08-22
8-K	2019-08-20
8-K	2019-08-07
8-K	2019-05-03
8-K	2019-03-04
8-K	2019-02-28
8-K	2019-02-07
8-K	2018-10-17
8-K	2018-08-23
8-K	2018-06-26
8-K	2018-04-24
8-K	2018-03-23
8-K	2018-03-19
8-K	2018-01-04

Liberated Solutions Financials

LIBE Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546,418	322,654	0	0	0	0	-853,740
1 800 Flowers Com (FLWS)	944,324	42%	13.3	6%	664,955	335,559	1,266,390	533,727	36,761	75,090	1,000,932
10x Genomics (TXG)	4,804,979	75%	-490.3	-2%	572,815	151,367	61,207	45,727	-9,603	-8,887	4,357,180
12 Retech (RETC)	0	32%	-0.1	-1,385%	1,118	20,421	625	199	-15,491	-14,800	966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	33,711	0%	0.4	-5%	164,088	108,405	18,194	0	-7,969	-8,017	-2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	18,527	23,194	27,219	6,699	-2,862	-1,433	3,396
1895 Bancorp of Wisconsin (BCOW)	46,152,715		12,508.1	-0%	441,187	382,722	0	0	-44	3,689	46,142,359
1st Constitution Bancorp (FCCY)	164,504	0%	4.4	1%	1,342,565	1,204,038	490	0	13,787	32,503	143,748
1st Franklin Financial (FFC)	3,551		-0.6	7%	905,107	644,730	0	0	62,078	80,004	-45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200,033		7.9	1%	6,691,070	5,858,028	0	0	70,061	136,342	1,072,548
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	1,849	0	0	-1,663	-1,654	250
21Vianet Group (VNET)	6,005,116			0%	11,150,717	5,787,533	0	0	0	0	3,344,095
22nd Century (XXII)	301,854	1%	-14.1	-36%	61,864	6,554	25,706	304	-22,433	-21,464	301,826
1Life Healthcare (ONEM)


Balance Sheet ($'000)	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2013-09-30	2013-12-31	2014-03-31	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2016-06-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-09-30
Cash	4	4	4	4	45	80	151	162	3	12	2	3	88	47	6	67	33	164	120	18	0	25	2,749
Accounts Receivable							20							43	49								24,273
Inventory								41	41	41		24											5,930
PP&E						0	0																4,809
Assets	48	45	43	42	57	93	221	245	86	53	26	27	270	90	55	67	33	164	120	18	0	25	37,993
Accounts Payable	12	26	22	44																			16,618
Long-Term Debt					50	50		446							38
Liabilities	47	73	107	133	218	326	426	512	587	595	334	606	1,019	1,021	1,056	1,107	1,144	1,033	780	750	667	699	96,832
Stockholders' Equity	0	-28	-64	-91	-161	-234	-204	-267	-501	-542	-308	-579	-749	-931	-958	-1,040	-1,111	-868	-680	-732	-667	-674	-58,839


Income Statement ($'000)	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2013-09-30	2013-12-31	2014-03-31	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2016-06-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-09-30
Revenue	0	0	0	0		0	39		0	0	62	0			0	-0			0				51,645
Cost of Revenue	0	0	0	0		0	0		0		17	0			0	-0			0				47,850
Gross Profit	0	0	0	0		0	39		0		45	0			0	0			0				3,795
R&D						0	0		0														105
SG&A	9	29	36	27		73	55		258	265	80	43	362	226	-321		69	440	204		57	73	764
Tax	0	0	0	0		0	0		0										5				32
Net Income	-9	-29	-36	-27		-73	-16		-258	-306	-40	-43	-462	-214	435	-761	-89	-426	-412		-68	-87	-53,145


Cash Flow ($'000)	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2013-09-30	2013-12-31	2014-03-31	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2016-06-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-09-30
Cash Operating	0	-0	0	0		-43	74		-258	-111	-85		-144	-183	-42	-77	-64	-83	-122		-82	-73	-6,902
Cash Investing	0	0	0	0			0						-183	139	0	0	0	0	0
Cash Financing	0	0	0	0		78	130		100	120	75		413	3	0	139	30	214	78		64	98	5,787